Table 4 Prevalence and odds ratios (OR) with 95% confidence intervals of previously known type 2 diabetes (T2D), screen-detected type 2 diabetes (ST2D), total type 2 diabetes (TT2D), impaired glucose tolerance (IGT), impaired fasting glucose (IFG), abnormal glucose tolerance (AGT = TT2D, IGT or IFG) of the study sample by waist circumference and gender
| MEN | WOMEN | |||||||
|---|---|---|---|---|---|---|---|---|
| WAIST CIRCUMFERENCE (cm) | WAIST CIRCUMFERENCE (cm) | |||||||
| < 94 | 94–101 | = 102 | p* | < 80 | 80–87 | = 88 | p* | |
| n | 427 | 437 | 500 | 351 | 355 | 755 | ||
| T2D, % | 2.1 | 5.5 | 15.2 | < 0.001 | 2.0 | 2.5 | 6.9 | < 0.001 |
| OR† | 1.0 (ref) |
2.50 (1.14–5.47) |
7.92 (3.89–16.11) | 1.0 (ref) |
1.20 (0.44–3.28) |
3.12 (1.39–6.98) | ||
| ST2D, % | 5.2 | 7.8 | 14.0 | < 0.001 | 2.3 | 3.7 | 11.8 | < 0.001 |
| OR | 1.0 (ref) |
1.46 (0.83–2.55) |
2.69 (1.63–4.46) | 1.0 (ref) |
1.56 (0.63–3.82) |
5.00 (2.39–10.49) | ||
| TT2D, % | 7.3 | 13.3 | 29.2 | < 0.001 | 4.3 | 6.2 | 18.7 | < 0.001 |
| OR | 1.0 (ref) |
1.82 (1.14–2.89) |
4.93 (3.24–7.51) | 1.0 (ref) |
1.40 (0.71–2.77) |
4.48 (2.57–7.80) | ||
| IGT, % | 9.6 | 18.1 | 19.6 | < 0.001 | 8.8 | 15.2 | 21.2 | < 0.001 |
| OR | 1.0 (ref) |
1.92 (1.28–2.90) |
2.01 (1.35–3.00) | 1.0 (ref) |
1.82 (1.13–2.93) |
2.50 (1.65–3.79) | ||
| IFG, % | 6.3 | 8.0 | 13.2 | < 0.001 | 0.9 | 4.8 | 6.8 | < 0.001 |
| OR | 1.0 (ref) |
1.36 (0.80–2.29) |
2.46 (1.53–3.96) | 1.0 (ref) |
5.97 (1.73–20.57) |
8.71 (2.69–28.20) | ||
| AGT, % | 23.2 | 39.4 | 62.0 | < 0.001 | 14.0 | 26.2 | 46.6 | < 0.001 |
| OR | 1.0 (ref) |
2.05 (1.51–2.79) |
5.23 (3.87–7.05) | 1.0 (ref) |
2.18 (1.47–3.23) |
5.02 (3.56–7.08) | ||